3rd Annual Gene Therapy for Neurological Disorders Europe

Temi della conferenza
Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic

With systemic toxicity challenges plaguing the AAV field, low-dose CNS indications are an ideal target for gene therapy.

Professional congress organizer (PCO)
Hanson Wade

https://go.evvnt.com/1075884-3?pid=4832

Ms. Emily Lincoln